Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Action antagonists, inhibitors |
Mechanism ABL2 antagonists(ABL proto-oncogene 2, non-receptor tyrosine kinase antagonists), EPHB2 antagonists(EPH receptor B2 antagonists), SIK2 inhibitors(Serine/threonine-protein kinase SIK2 inhibitors) + [1] |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC47H55N9O5S |
InChIKeyKEGVGSFRDCGPAX-INBBZAOVSA-N |
CAS Registry2769850-28-2 |